Close Menu

NEW YORK — SG Blocks has acquired the nonexclusive US distribution rights to Osang Healthcare's GeneFinder COVID-19 Plus RealAmp Kit for the detection of SARS-CoV-2, the companies said on Tuesday.

New York City-based SG Blocks designs and builds structures using maritime-grade shipping containers. Under the terms of the deal, it will have nonexclusive sales, marketing, and distribution rights to the test in the US for one year. Additional terms were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test.